• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CDNA

CDNA

CareDx, Inc

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD22.31

+0.24 (+1.09%)

Rating:C-

Company Profile

CEO

John Walter Hanna Jr.

IPO Date

2014-07-17

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$22.11

Prev. Close

$22.07

Day Low

$21.58

Day High

$22.32

52W Low

$10.96

52W High

$23.24

Market Cap

$1.15B

Volume

0.70M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

8.6%

Avg Negative

2.7%

Avg Neutral

88.6%

News Feed

CareDx Showcases Leadership in Global Transplantation at ESOT 2021

GlobeNewsWire·8/26/2021·↑ positive

CareDx: A Near-Term Capital-Gainer Among Healthcare Diagnostics, Say Market-Makers

Seeking Alpha·8/15/2021·↓ negative

CareDx, Inc. (CDNA) CEO Reg Seeto on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/30/2021·↓ negative

CareDx (CDNA) Beats Q2 Earnings and Revenue Estimates

Zacks Investment Research·7/29/2021·↑ positive

CareDx Launches ACROBAT Study to Potentially Change Care Paradigm for Stem Cell Transplant Patients

GlobeNewsWire·7/26/2021·↑ positive

CareDx to Report Second Quarter 2021 Financial Results

GlobeNewsWire·7/15/2021·↑ positive

CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients

GlobeNewsWire·7/1/2021·↑ positive

CareDx to Participate in Raymond James 2021 Human Health Innovation Conference

GlobeNewsWire·6/16/2021·↑ positive

CareDx congratulates Hannah Valantine for her State of the Art Lecture at ATC on Transplant Equity

GlobeNewsWire·6/9/2021·↑ positive

CareDx Presents Landmark KOAR-1000 Data, Demonstrating Higher 1-Year Graft Survival and Reduction in Biopsies through ARTS Surveillance

GlobeNewsWire·6/7/2021·↑ positive